-
801
Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in...
Published 2022“…The primary outcome of the study was the change in the time spent in the target in range (TIR) of 70–180 mg/dl and HbA1c from baseline (MDI + CGM, 1 week) to study phase (AHCL, 12 weeks). …”
-
802
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
Published 2023“…By 2050, 89 (43·6%) of 204 countries and territories will have an age-standardised rate greater than 10%. InterpretationDiabetes remains a substantial public health issue. …”
Get full text
Get full text
Get full text
article -
803
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
Published 2021“…However, over the past decade, global vaccine coverage broadly plateaued; 94 countries and territories recorded decreasing DTP3 coverage since 2010. Only 11 countries and territories were estimated to have reached the national GVAP target of at least 90% coverage for all assessed vaccines in 2019.…”
-
804
Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
Published 2024“…Additionally, we introduced two new metrics to our reporting: prevalence of unsuppressed viraemia (PUV), which represents the proportion of the population without a suppressed level of HIV (viral load <1000 copies per mL), and period lifetime probability of HIV acquisition, which quantifies the hypothetical probability of acquiring HIV for a synthetic cohort, a simulated population that is aged from birth to death through the set of age-specific incidence rates of a given time period. FindingsGlobal new HIV infections decreased by 21·9% (95% UI 13·1–28·8) between 2010 and 2021, from 2·11 million (2·02–2·25) in 2010 to 1·65 million (1·48–1·82) in 2021. …”
Get full text
Get full text
Get full text
article -
805
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
Published 2024“…Cause-specific mortality was modelled using mixed-effects models with SDI and time as the main covariates, and the combined impact of causal risk factors as an offset in the model. …”
Get full text
Get full text
Get full text
article -
806
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Bur...
Published 2020“…Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. …”
Get full text
Get full text
Get full text
article -
807
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Bur...
Published 2020“…Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. …”
-
808
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic anal...
Published 2020“…FindingsThe global TFR decreased from 2·72 (95% uncertainty interval [UI] 2·66–2·79) in 2000 to 2·31 (2·17–2·46) in 2019. …”
Get full text
Get full text
Get full text
article -
809
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Published 2022“…</p><h3>Interpretation</h3><p dir="ltr">The prevalence of chronic HBV infection declined over time, particularly in children younger than 5 years, since the introduction of <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/hepatitis-b-vaccination" target="_blank">hepatitis B vaccination</a>. …”
-
810
Enhanced oil recovery using hyperbranched polyglycerol polymer-coated silica nanoparticles
Published 2021“…A D<sub>PSiMNPs</sub> = 100 mg/L was sufficient to achieve %η<sub>dem</sub> of 99.4% for C<sub>oil</sub> = 100 mg/L and slightly decreased to ~93% for C<sub>oil</sub> ~4000 mg/L. The PSiMNPs can be reused up to 15 times with a steady %η<sub>dem</sub> of 89.1% for C<sub>oil</sub> = 100 mg/L and 88.6% for C<sub>oil</sub> = 4000 mg/L. …”
-
811
Dynamics of Neisseria gonorrhoeae transmission among female sex workers and clients: A mathematical modeling study
Published 2024“…In the common low-partner-number HSWNs, a significant proportion of NG incidence occurs among FSWs, with NG prevalence 13 times higher among FSWs than clients, and three times higher among clients than their spouses. …”
Get full text
Get full text
Get full text
article -
812
Carbonate effects on hexavalent uranium removal from water by nanocrystalline titanium dioxide
Published 2006“…However, the capacity of the nanocrystalline titanium dioxide to remove U(VI) from water decreased in the presence of inorganic carbonate at pH > 6.0. …”
Get full text
Get full text
Get full text
article -
813
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic anal...
Published 2020“…Findings The global TFR decreased from 2·72 (95% uncertainty interval [UI] 2·66–2·79) in 2000 to 2·31 (2·17–2·46) in 2019. …”
-
814
Critical Illness, Gastrointestinal Complications, and Medication Therapy during Enteral Feeding in Critically Ill Adult Patients
Published 2010“…EN in critically ill patients provides the benefits of maintaining gut functionality, integrity, and immunity as well as decreasing infectious complications. However, the ability to provide timely and adequate EN to critically ill patients is often hindered by GI motility disorders and complications associated with EN. …”
Get full text
Get full text
Get full text
Get full text
article -
815
Barriers of Additive Manufacturing Adoption in United Arab Emirates Automotive Supply Chain
Published 2023“…AM offers a tremendous opportunity by improving adaptability and efficiency of the supply chain such as reducing lead times, decreasing the dependence on foreign suppliers, and promoting sustainability in manufacturing processes. …”
Get full text
-
816
Analysis of Innovative Vapor Compression and Thermal Energy Storage Systems Using Alternative Refrigerants
Published 2016Get full text
doctoralThesis -
817
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Published 2021“…During the same period, age-standardised rates of stroke incidence decreased by 17·0% (15·0–18·0), mortality decreased by 36·0% (31·0–42·0), prevalence decreased by 6·0% (5·0–7·0), and DALYs decreased by 36·0% (31·0–42·0). …”
-
818
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global...
Published 2020“…In 2017, age-standardised incidence was 2·7 times higher, mortality 2·9 times higher, and DALYs 3·0 times higher in males than in females. …”
-
819
Deep Reinforcement Learning Powered IRS-Assisted Downlink NOMA
Published 2022“…As the imperfection increases by ten times, the rate decreases by more than 10%.</p><h2>Other Information</h2><p dir="ltr">Published in: IEEE Open Journal of the Communications Society<br>License: <a href="https://creativecommons.org/licenses/by/4.0/legalcode" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1109/ojcoms.2022.3165590" target="_blank">https://dx.doi.org/10.1109/ojcoms.2022.3165590</a></p>…”
-
820
PSA-activated proaerolysin as a prostate specific cancer therapy
Published 2006“…Activity toward proaerolysin was decreased 10-100 fold for each of the proteases tested except PSA, which showed a 4-fold increase in activity against the modified protein. …”
Get full text
Get full text
Get full text
conferenceObject